Literature DB >> 14718214

Cigarette smoking and increased risk of mucinous epithelial ovarian cancer.

Yuqing Zhang1, Patricia F Coogan, Julie R Palmer, Brian L Strom, Lynn Rosenberg.   

Abstract

Several studies have reported that cigarette smoking is associated with an increased risk of mucinous ovarian cancer, but other studies have failed to find such a relation. Using data from the Case-Control Surveillance Study, begun in four US cities in 1976, the authors conducted a case-control study (1976-2001) to examine the association between cigarette smoking and the risk of ovarian cancer of different cell types. Among 709 incident cases of epithelial ovarian cancer, 402 were serous, 74 were mucinous, 106 were endometrioid, and 127 were of other cell types. For mucinous ovarian cancer, the odds ratios were 1.5 (95% confidence interval (CI): 0.7, 3.4) among women who smoked less than one pack of cigarettes per day, 1.4 (95% CI: 0.6, 3.5) among women who smoked one pack per day, and 2.9 (95% CI: 1.2, 7.5) among women who smoked more than one pack per day, relative to never smokers. The odds ratios were 2.5 (95% CI: 1.1, 5.4) for ex-smokers and 1.4 (95% CI: 0.7, 2.9) for current smokers. While women with up to 15 pack-years of smoking had an almost 2.5 times' increased risk of mucinous ovarian cancer, such an increased risk was not found among those with more than 15 pack-years of smoking. There was no association between cigarette smoking and epithelial ovarian cancer of other cell types. Despite inconsistencies in the data, these results strengthen the evidence that cigarette smoking may play a role in the development of mucinous ovarian cancer but not ovarian cancer of other cell types.

Entities:  

Mesh:

Year:  2004        PMID: 14718214     DOI: 10.1093/aje/kwh015

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Unbalanced estrogen metabolism in ovarian cancer.

Authors:  Muhammad Zahid; Cheryl L Beseler; James B Hall; Tricia LeVan; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Int J Cancer       Date:  2014-01-25       Impact factor: 7.396

2.  Nicotine inhibits MAPK signaling and spheroid invasion in ovarian cancer cells.

Authors:  Sarah J Harmych; Jay Kumar; Mesa E Bouni; Deborah N Chadee
Journal:  Exp Cell Res       Date:  2020-07-07       Impact factor: 3.905

3.  Changing trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.

Authors:  Elif Demirci; Ferah Tuncel Daloglu; Muhammet Calik; Eren Altun; Sare Sipal; Bunyamin Borekci
Journal:  Eurasian J Med       Date:  2014-08-26

Review 4.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

5.  Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse.

Authors:  Kun-Ming Chen; Shang-Min Zhang; Cesar Aliaga; Yuan-Wan Sun; Timothy Cooper; Krishnegowda Gowdahalli; Junjia Zhu; Shantu Amin; Karam El-Bayoumy
Journal:  Chem Res Toxicol       Date:  2012-01-06       Impact factor: 3.739

Review 6.  Association between Cigarette Smoking and Histotype-Specific Epithelial Ovarian Cancer: A Review of Epidemiologic Studies.

Authors:  Aili Zhou; Albina N Minlikeeva; Sadat Khan; Kirsten B Moysich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-01       Impact factor: 4.254

7.  Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.

Authors:  Hannah P Yang; Britton Trabert; Megan A Murphy; Mark E Sherman; Joshua N Sampson; Louise A Brinton; Patricia Hartge; Albert Hollenbeck; Yikyung Park; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-11-10       Impact factor: 7.396

8.  Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.

Authors:  S Dholariya; R Mir; M Zuberi; P Yadav; G Gandhi; N Khurana; A Saxena; P C Ray
Journal:  Clin Transl Oncol       Date:  2015-07-25       Impact factor: 3.405

9.  Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.

Authors:  Liangdan Tang; Junzheng Yang; Shu-Kay Ng; Noah Rodriguez; Pui-Wah Choi; Allison Vitonis; Kui Wang; Geoffrey J McLachlan; Robert J Caiazzo; Brian C-S Liu; William R Welch; Daniel W Cramer; Ross S Berkowitz; Shu-Wing Ng
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

10.  Risk of other cancers in individuals with a family history of pancreas cancer.

Authors:  Michele L Cote; Maryjean Schenk; Ann G Schwartz; Fawn D Vigneau; Margaret Kinnard; Joel K Greenson; Jon P Fryzek; Gui Shuang Ying; David H Garabrant
Journal:  J Gastrointest Cancer       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.